Illumina inc stock.
The average price predicted for Illumina Inc (ILMN) by analysts is $136.31, which is $38.7 above the current market price. The public float for ILMN is 158.12M, and at present, short sellers hold a 3.27% of that float. On November 21, 2023, the average trading volume of ILMN was 2.01M shares. ILMN) stock’s latest price […]
Nov 29, 2023 · Delivering Value to Investors. A global leader in DNA sequencing and array-based technologies, Illumina is fueling advancements in life sciences, oncology, reproductive health, genetic disease, agriculture, microbiology, and other emerging segments. We are dedicated to improving human health by unlocking the power of the genome. Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 7.17% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.55 and as low as $89.00. Year to date, Illumina, Inc.’s stock ...Nov 3, 2022 · Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022. Nov 3, 2022. Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis. GAAP diluted loss per share of $ (24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share for Q3 2022 ... Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic ... Illumina (ILMN) Stock Key Data. Summary ...
Dec 1, 2023 · 17 equities research analysts have issued 1 year price targets for Illumina's shares. Their ILMN share price targets range from $100.00 to $328.00. On average, they predict the company's share price to reach $194.56 in the next year. This suggests a possible upside of 77.2% from the stock's current price. SAN DIEGO, March 2, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Myriad Genetics Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the expansion of a strategic partnership to broaden access to and availability of oncology homologous ...
0.67%. $6.69B. Invitae Corp. 0.66%. $155.59M. ILMN | Complete Illumina Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief …Find out the direct holders, institutional holders and mutual fund holders for Illumina, Inc. (ILMN).Illumina’s stock has been in a long-term downtrend since August 2021. It has been in a messy trading range since May 2022 and just recently closed below the low of that range based on weekly prices.SAN DIEGO, April 3, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it will appeal the Federal Trade Commission's ("FTC") decision ordering the unwinding of Illumina's acquisition of GRAIL.. Illumina intends to file a petition for review promptly with a US Court of Appeals and will seek expedited treatment of the appeal. …Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325
EU regulators will order US biotech Illumina to sell cancer test developer Grail after it bought the $8bn company without the approval of Brussels, according to three people with direct knowledge ...
Feb 7, 2023 · Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis.
Shares of Illumina Inc. slid 0.14% to $119.47 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...Nov 30, 2023 · A high-level overview of Illumina, Inc. (ILMN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Detailed Financial Results for Illumina. Our earnings reports, supplementary data, 10Q and 10K, and selected other documents are available below by quarter. Please reach out to our Investor Relations …6 hours ago · THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 2023. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) certain of the ... 9.12M. BABA. 72.93. -2.60%. 9.87M. View today's Illumina Inc stock price and latest ILMN news and analysis. Create real-time notifications to follow any changes in the live stock price.ILLUMINA INC 0J8Z Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.The base stock consideration was subject to a collar, where the number of shares issued at closing varied in the event the 20-trading-day volume weighted average price of Illumina stock as of 10 trading days prior to closing is between $295 and $399 but was fixed at 11.3 million shares if such volume weighted average share price is above $399 ...
Illumina responds to European Commission's divestiture order. SAN DIEGO, Oct. 13, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), has received an order from the European Commission (EC) directing the company to divest GRAIL. Receipt of the order is an important next step in evaluating divestiture options for GRAIL.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...7 hours ago · New York, New York-- (Newsfile Corp. - December 4, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. (NASDAQ: ILMN) between May 1, 2023 and October 16, 2023, both dates inclusive (the "Class Period"), of the important January 9, 2024 lead plaintiff deadline. Interested parties may access the live teleconference through the Investor Info section of Illumina's website at investor.illumina.com. Alternatively, individuals can access the call by dialing 866.400.0049 or +1.323.794.2149 outside North America, both with Conference ID 1991305.Contact Email [email protected]. Phone Number 858.202.4500. Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions ...The U.S. Securities and Exchange Commission (SEC) has begun an investigation into Illumina's $7.1 billion acquisition of cancer detection test maker Grail , the gene sequencing company said in a ...Illumina sees full-year adjusted profit per share to be between $0.60 and $0.70, versus its prior forecast range of $0.75 to $0.90. It makes tools and provides sequencing services to hospitals ...
Nov 30, 2023 · Illumina Inc.’s stock growth can be attributed to the overall success of the stock market, with the S&P 500 Index and the Dow Jones Industrial Average experiencing positive movements. The company’s consecutive days of gains and increased trading volume also indicate growing investor interest.
Illumina said on Friday it would divest cancer test maker Grail in 12 months, according to the terms of the European Commission's order, if the life sciences company does not win its challenge in ...Illumina Inc. Stock Performance and Analysis: October 11, 2023. On October 11, 2023, Illumina Inc. (ILMN) had a previous close of $138.79 and opened at $139.73. Throughout the day, the stock’s range fluctuated between $136.66 and $139.73. The trading volume for the day was 29,406 shares, significantly lower than the average …281.12M. 294.89%. Get the latest Illumina, Inc. (ILU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.9.12M. BABA. 72.93. -2.60%. 9.87M. View today's Illumina Inc stock price and latest ILMN news and analysis. Create real-time notifications to follow any changes in the live stock price.Oct 5, 2023 · Interested parties may access the live teleconference through the Investor Info section of Illumina's website at investor.illumina.com. Alternatively, individuals can access the call by dialing 866.400.0049 or +1.323.794.2149 outside North America, both with Conference ID 1991305. Illumina, Inc. Stock Price History. Illumina, Inc.’s price is currently down 13% so far this month. During the month of November, Illumina, Inc.’s stock price has reached a high of $118.38 and a low of $89.00. Over the last year, Illumina, Inc. has hit prices as high as $238.71 and as low as $89.00. Year to date, Illumina, Inc.’s stock is ...Mar 2, 2023 · SALT LAKE CITY, March 02, 2023 (GLOBE NEWSWIRE) -- Myriad Genetic, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA ... Incorporated in 1998, Illumina, Inc. is a California-based company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.Jul 7, 2023 · Illumina and S&P 500 Performance During 2007-08 Crisis ILMN stock declined from $87 in August 2008 (its pre-crisis peak) to around $31 in March 2009 (as the markets bottomed out), implying that it ...
Illumina’s stock has been in a long-term downtrend since August 2021. It has been in a messy trading range since May 2022 and just recently closed below the low of that range based on weekly prices.
MarketWatch IBD Lists & Rankings Barron's 400 Market Data ILMN U.S.: Nasdaq 96.22 - 98.82 Charles River Laboratories International Inc. 10x Genomics Inc. Pacific …
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Illumina Korea Hi Investment & Securities building 66 Yeoidaero Yeoungdeungpo-gu Seoul Korea 07325The reduction in workforce commenced on June 21 and will result in charges of about $25 to $35 million, the company said, with majority incurred in the second quarter. Illumina's core global ...Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions. Company profile page for Illumina Inc including stock price, company news, press releases, executives, board members, and contact informationIllumina for Startups initiatives include Illumina Accelerator, founded in 2014, and Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina, launching Fall 2021. Illumina Accelerator is a company creation engine co-located with Illumina research and development sites in San Francisco Bay Area and Cambridge, UK.Oct 5, 2023 · Interested parties may access the live teleconference through the Investor Info section of Illumina's website at investor.illumina.com. Alternatively, individuals can access the call by dialing 866.400.0049 or +1.323.794.2149 outside North America, both with Conference ID 1991305. Alliance aims to accelerate therapeutic development and expand the diversity of genomic data through inclusion of more samples from currently underrepresented ancestries . SAN DIEGO, July 18, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with …281.12M. 294.89%. Get the latest Illumina, Inc. (ILU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. October 11, 2023. SAN DIEGO, Oct. 11, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) posted a stewardship-focused presentation for investors on the Events & Presentations section of its investor relations website, investor.illumina.com, on Wednesday, October 11, 2023. Members of Illumina's Board of Directors and senior …Oct 20, 2023 · Illumina, Inc.’s stock is NA in 2023, NA in the previous five trading days and down 41.56% in the past year. Currently, Illumina, Inc. does not have a price-earnings ratio. Illumina, Inc.’s trailing 12-month revenue is $4.5 billion with a -93.8% net profit margin. Year-over-year quarterly sales growth most recently was 1.2%. Complete Illumina Inc. stock information by Barron's. View real-time ILMN stock price and news, along with industry-best analysis.
Our shares are quoted on the Nasdaq National Market under the symbol “ILMN.” The last reported sale price of our common stock on May 10, 2006 was $29.50 per ...NEW YORK, NY / ACCESSWIRE / December 4, 2023 / If you suffered a loss on your Illumina, Inc. (NASDAQ:ILMN) investment and want to learn about a potential recovery under the federal securities laws ...Illumina, Inc. Common Stock is estimated to report earnings on 08/10/2023. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor ...Instagram:https://instagram. best nursing insurancesibgflu games 12sbest self storage reits Get the latest Illumina, Inc. (ILU) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Illumina Inc Stock Forecast: Analysts Predict 15.52% Increase, Consensus to Buy. On May 18, 2023, Illumina Inc (ILMN) stock closed at $201.26. The 18 analysts offering 12-month price forecasts for ILMN have a median target of $232.50, with a high estimate of $334.00 and a low estimate of $150.00. The median estimate represents a … hyundai motors stockets stock Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022. February 7, 2023. Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis. Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis. ritax Discover historical prices for ILMN stock on Yahoo Finance. View daily, weekly or monthly format back to when Illumina, Inc. stock was issued. ... Illumina, Inc. (ILMN) NasdaqGS - NasdaqGS Real ...Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022. Nov 3, 2022. Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis. GAAP diluted loss per share of $ (24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share for Q3 2022 ...Illumina's shares rose 2.2% to $204.98 in premarket trading on Monday. The company's shares have lost about 60% of their value since completing the Grail deal in 2021.